This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Minghui Pharmaceutical (Hangzhou) Limited, Minghui Pharmaceutical (Shanghai) Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2026
Title: Yile Chen: Inventor in Pharmaceutical Innovation.
Introduction
Yile Chen is an inventor based in Hangzhou, China. His work includes a patent concerning a toxin molecule designed for potential use in antibody-drug conjugates. The supplied information lists 1 patent associated with him.
Latest Patents
The patent, “Toxin Molecule Suitable for Antibody-Drug Conjugate,” describes a compound represented by Formula (I), or a pharmaceutically acceptable salt or hydrate of that compound. The invention proposes using the compound to prepare a pharmaceutical composition for treating diseases associated with tumor cell proliferation.
Career Highlights
The information provided associates Chen with Minghui Pharmaceutical (Hangzhou) Limited and Minghui Pharmaceutical (Shanghai) Limited. His listed patent reflects work in pharmaceutical research focused on compounds intended for antibody-drug conjugates.
Collaborations
The patent’s stated application connects the invention to research into antibody-drug conjugates and potential treatments for diseases involving tumor cell proliferation. The available information does not identify specific co-inventors or other collaborators.
Conclusion
Yile Chen’s listed patent centers on a toxin molecule proposed for pharmaceutical use in antibody-drug conjugates, highlighting his contribution to research into potential cancer treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile